Lupin Fact Sheet, Lupin Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Fact Sheet    (LUPL)


RSVP REQUIRED: Your Invitation to Attend the Super Smallcaps Summit


Here is the latest financial fact sheet of Lupin. For more details, see the Lupin quarterly results and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN Price History

Price Rs 950.7
Mkt Cap Rs m 431,360
Vol '000 93.6
P/E X 25.9
P/CF X 20.4
EPS (TTM) Rs 36.7
% ch % -1.8
No. of shares m 453.73
% ch week % -3.2
% ch 1-mth % -1.7
% ch 12-mth % -7.6
52 week H/L Rs 1,267.5/856.0
(As on Sep 17, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
LUPIN EQUITY SHARE DATA
High Rs1,7501,4659868821,122 
Low Rs1,384727720505576 
Sales per share (Unadj.) Rs385.0349.0370.2371.7334.2 
Earnings per share (Unadj.) Rs56.65.613.5-6.027.0 
Diluted earnings per shareRs56.35.613.5-6.027.0 
Cash flow per share (Unadj.) Rs76.829.732.215.446.6 
Dividends per share (Unadj.) Rs7.505.005.006.006.50 
Adj. dividends per shareRs7.464.984.995.996.50 
Avg Dividend yield %0.50.50.60.90.8 
Book value per share (Unadj.) Rs295.0295.6298.9272.0300.1 
Adj. book value per shareRs293.7294.6298.1271.6300.0 
Shares outstanding (eoy) m451.58452.08452.49453.00453.68 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.13.12.31.92.5 
Avg P/E ratio x27.7194.463.1-114.831.4 
P/CF ratio (eoy) x20.437.026.545.118.2 
Price / Book Value ratio x5.33.72.92.52.8 
Dividend payout %13.288.737.0-99.324.0 
Avg Mkt Cap Rs m707,508495,505386,068314,199385,072 
No. of employees `000NANANANANA 
Total wages/salary Rs m28,49528,64727,70229,86828,259 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
LUPIN INCOME DATA
Net Sales Rs m173,857157,765167,514168,366151,630 
Other income Rs m1,0651,5043,3304,8381,363 
Total revenues Rs m174,922159,269170,844173,203152,993 
Gross profit Rs m44,93116,83223,29017,22325,669 
Depreciation Rs m9,12210,8598,4619,7028,874 
Interest Rs m1,5252,0443,0253,6301,406 
Profit before tax Rs m35,3495,43315,1348,72816,751 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m9,7852,8859,01711,4664,485 
Profit after tax Rs m25,5642,5486,117-2,73712,266 
Gross profit margin %25.810.713.910.216.9 
Effective tax rate %27.753.159.6131.426.8 
Net profit margin %14.71.63.7-1.68.1 
LUPIN BALANCE SHEET DATA
Current assets Rs m119,529122,095138,536154,132139,864 
Current liabilities Rs m61,20650,95661,29992,25284,361 
Net working cap to sales %33.545.146.136.836.6 
Current ratio x2.02.42.31.71.7 
Inventory Days Days6515606269 
Debtors Days Days90120112118108 
Net fixed assets Rs m141,467133,793133,61893,96394,439 
Share capital Rs m903904905906907 
"Free" reserves Rs m132,335132,753134,333122,314135,229 
Net worth Rs m133,238133,657135,238123,220136,136 
Long term debt Rs m56,47864,24566,41717,933161 
Total assets Rs m260,996255,888272,154248,095234,302 
Interest coverage x24.23.76.03.412.9 
Debt to equity ratio x0.40.50.50.10 
Sales to assets ratio x0.70.60.60.70.6 
Return on assets %10.41.83.40.45.8 
Return on equity %19.21.94.5-2.29.0 
Return on capital %19.43.89.08.813.3 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m81,88553,14159,41451,45051,027 
Fx outflow Rs m21,50619,33522,28219,47021,081 
Net fx Rs m60,37833,80737,13231,98029,946 
LUPIN CASH FLOW
From Operations Rs m 41,135 17,512 16,660 14,688 18,218 
From Investments Rs m -25,274 4,699 -32,825 11,070 -12,396 
From Financial Activity Rs m 4,332 -14,921 7,441 -8,906 -18,853 
Net Cashflow Rs m 20,193 7,290 -8,724 16,853 -13,031 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 46.8%
Institution 40.7%
Non-Institution 12.5%
Total 100.0%
Free Float 53.2%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Kalpataru Inspire 3rd Floor, Off. Western Express Highway, Santacruz (East), Mumbai - 400055
E-MAIL info@lupin.com WEB www.lupin.com
TEL 022 6640 2323 FAX 022 6640 8131
SECTOR PHARMACEUTICALS GROUP Lupin
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.7

Read: LUPIN 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   VENUS REMEDIES  SUVEN PHARMACEUTICALS  NECTAR LIFESCIENCE  ALBERT DAVID  TRIMURTHI DRUGS  

Compare LUPIN With:   VENUS REMEDIES  SUVEN PHARMACEUTICALS  NECTAR LIFESCIENCE  ALBERT DAVID  TRIMURTHI DRUGS  




Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN

MORE ON LUPIN

COMPARE LUPIN WITH

MARKET STATS